The effect of hyperphenylalaninaemia on the metabolism of ketone bodies in vivo and in vitro by developing rat brain was investigated. The incorporation in vivo of ["4Claceto-acetate into cerebral lipids was decreased by both chronic (for 3 days) and acute (for 6h) hyperphenylalaninaemia induced by injecting phenylalanine into 1-week-old rats. -In studies in vitro it was observed that the incorporation of the radioactivity from (14C]-acetoacetate and 3-hydroxy[14C]butyrate into cerebral lipids was inhibited by phenyl.
The effect of hyperphenylalaninaemia on the metabolism of ketone bodies in vivo and in vitro by developing rat brain was investigated. The incorporation in vivo of ["4Claceto-acetate into cerebral lipids was decreased by both chronic (for 3 days) and acute (for 6h) hyperphenylalaninaemia induced by injecting phenylalanine into 1-week-old rats. -In studies in vitro it was observed that the incorporation of the radioactivity from (14C]-acetoacetate and 3-hydroxy[14C]butyrate into cerebral lipids was inhibited by phenyl.
pyruvate, but not by phenylalanine. Phenylpyruvate also inhibited the incorporation of 3H from 3H20 into lipids by brain slices metabolizing either 3-hydroxybutyrate or acetoacetate in the presence ofglucose. These findings suggest that the decrease in the incorporation In vivo of ["4C ]acetoacetate into cerebral lipids in hyperphenylalaninaemic rats is most likely caused by phenylpyruvate and not by phenylalanine. Phenylpyruvate as well as phenylalanine had no inhibitory effects on ketone-body-catabolizing enzymes, namely 3-hydroxybutyrate dehydrogenase, 3-oxo acid CoA-transferase and acetoacetyl-CoA thiolase, in rat brain. Phenylpyruvate but not phenylalanine inhibited the activity of the 2-oxoglutarate dehydrogenase complex from rat and human brain. These findings suggest that the metabolism of ketone bodies is impaired in brains of untreated phenylketonuric patients, and in turn may contribute to the diminution of mental development and function associated with phenylketonuria.
The chemical analysis of brains from untreated phenylketonuric patients at autopsy has revealed a marked decrease in the lipid content (Crome et al., 1962; Menkes, 1968; Menkes & Aeberhard, 1969) . Hyperphenylalaninaemia induced in laboratory animals by dietary means has also been shown to cause a decrease in cerebral lipids (Chase & O'Brien, 1970; Clarke & Lowden, 1969) . The incorporation in vivo oflabelled acetate and glucose into brain lipids is decreased in hyperphenylalaninaemic rabbits (Barbato et al., 1968) and rats (Shah et al., 1970) . The synthesis of cholesterol from [14C]mevalonate is diminished by brains from hyperphenylalaninaemic rats (Shah et al., 1969) . The decrease in cerebral lipids in hyperphenylalaninaemic rats is largely attributed to their low myelin content (Shah et al., 1972; Johnson & Shah, 1973) , which in turn reflects a decrease in lipid synthesis.
During the postnatal period the developing rat brain is able to metabolize glucose and ketone bodies for energy production (for a review see Krebs et al., 1971) . Edmond (1974) (b) Acute. Litters (7 days old) were randomly divided into two groups. Acute hyperphenylalaninaemia was induced in one group by injecting intraperitoneally 0.5 ml of 2.5% phenylalanine in 0.9% NaCl three times each 2h apart. The control group received 0.5ml of0.9 % NaCl three times by the same route. Immediately after the last injection of phenylalanine or NaCl solution, 50O1 of [3-14C]acetoacetate (5 x 105d.p.m.) was injected into each pup as described above. Pups were then separated from the mother and killed 2h later.
After the pups were killed brains were rapidly removed and divided into two halves. One portion was weighed, homogenized in 5 ml of50mM-potassium phosphate buffer, pH7.4, and centrifuged at lOOOOOg for 1 h. To a sample (0.5 ml) of this supernatant was added 0.1 ml of 36% (w/v) HC104 to remove any 14CO2. The acid-stable radioactivity was counted in Diotol scintillation fluid (Herberg, 1960) . The other half of the brain was weighed, flattened with a spatula and transferred into 15 ml of chloroform/methanol (2:1, v/v) and left overnight. The tissue was shaken vigorously for 1 min, and the extracted lipids were separated into non-saponifiable (mainly sterols) and saponifiable (fatty acids) fractions (Folch et al., 1957) 
Studies in vitro
Preparation and incubation ofbrain slices. Animals were decapitated and slices of rat cerebral cortex of about 0.4mm in thickness (average wt. 75mg) were prepared by using a hand-microtome at 25°C (Manjo & Bunker, 1957) . Only the first slice was used and was immediately transferred to a 25ml Erlenmeyer flask containing 3ml of oxygenated high-K+ Krebs-Ringer bicarbonate buffer, pH7.4 (a fivefold increase in KCl replacing a corresponding number of milliequivalents of NaCi) (Berl et at., 1968) . The buffer contained labelled substrates and other compounds as indicated in Tables 2-4. The flask was gassed with 02+C02 (95: 5) and sealed with a rubber serum stopper equipped with a hanging polyethylene centre well. The flask was placed in a shaking water bath at 37°C for 1 h. At the end of the incubation period, 0.3ml of hydroxide of Hyamine-lOX was injected into the centre well and 0.5 ml of 36% (w/v) HCI04 was injected into the medium to stop the reaction and to ensure complete release of CO2. After additional shaking for 40min, the contents of the cup were transferred into toluene scintillation fluid (Patel, 1974b) , and the radioactivity in 14CO2 was determined. The tissue was removed and rinsed three times in water and placed in a tube containing lOml of chloroform/methanol (2:1, v/v). The lipids were separated into non-saponifiable and saponifiable fractions and the radioactivity was determined as described above. In experiments in which 3H20 was used, the chloroform/methanol extracts were washed with CaC12 solution (0.05%Y.) for six to eight times until the aqueous phase became free of radioactivity by contaminating 3H20. The results are expressed as the amount of radioactive substrate incorporated into the products investigated.
Preparation of brain extracts and determination of enzyme activities. Brain homogenates (20%, w/v) were prepared in ice-cold sucrose buffer (0.25M-sucrose/ lOmM-Tris / HCI / 1 nM-2-mercaptoethanol, pH7.4) by homogenizing at about 500rev./min for min in a glass homogenizer fitted with a Teflon pestle. The homogenate was sonicated for two 30s periods at about 60W (model W185, Heat SystemsUltrasonics, Plainview, N.Y., U.S.A.) and was then centrifuged for 20min at 30000g . The supernatant fluid was used to determine enzyme activities. The activity of 3-hydroxybutyrate dehydrogenase (EC 1.1.1.30) was measured spectrophotometrically (Smith et al., 1969) and colorimetrically Walker, 1954 ). An appropriately diluted solution of commercially available preparation of3-hydroxybutyrate dehydrogenase was also tested to determine the effect of phenylpyruvate on this enzyme (Smith et al., 1969) . Activities of acetoacetyl-CoA thiolase (EC 2.3.1.9) and 3-oxo acid CoA-transferase (EC 2.8.3.5.) were determined by measuring the decrease in E303 of acetoacetyl-CoA in the presence of CoA or succinate respectively .
Mitochondria from rat brain were isolated by the method of Clark & Nicklas (1970) . The mitochondria isolated from rat brain by this procedure have been shown to have functional integrity, as judged by the P/O and the respiratory-control ratios (Patel, 1972) .
Assay of 2-oxoglutarate dehydrogenase complex. The activity of the 2-oxoglutarate dehydrogenase 1976 complex was measured in brain preparation as described (Patel, 1974b) . Briefly, the washed mitochondria from rat brain were suspended in a phosphate buffer, pH7.4 (lOmm-potassium phosphate/1mM-dithiothreitol/lmM-EDTA), and were subjected to three cycles of freezing and thawing immediately before the activity was assayed. The composition of the reaction mixture is described in the legend of Fig.  1 . Incubations were carried out in duplicates in sealed flasks and 14C02 was collected as described above.
Adult human brain cortex was obtained at autopsy (within 16h after death) and placed in ice-cold 0.3M-sucrose. Homogenates of brain (20%, w/v) in 0.3M-sucrose were prepared and centrifuged at 100OOOg for 30min. The supernatant was discarded and the pellet was resuspended in the phosphate buffer, pH7.4. The suspension was subjected to three cycles of freezing and thawing immediately before the activity of 2-oxoglutarate dehydrogenase complex was assayed as described above. A munit of activity is defined as The oxidation of 3-hydroxy[3-14C]butyrate to CO2 by cerebral-cortex slices from suckling rats was higher than that from adult rats (Table' 2). This observation is consistent with the higher activities ofketonebody-utilizing enzymes in brains from suckling rats as compared with adults . The incorporation in vitro of [3-14C] acetoacetate and 3-hydroxy[3-14C]butyrate into cerebral lipids by 1-week-old rats was markedly stimulated in the presence of glucose (compare the results for 7-day-old rats in 'table 2 with those reported in Table 3 ). This marked stimulation oflipid synthesis may be attributed to the generation of NADPH via the pentose phosphate pathway. Also the rate of incorporation of labelled ketone bodies into cerebral lipids was the highest at about 7 days postnatally and decreased markedly at the time ofweaning (Patel, 1975) ; the results for adult (Table  2 ) and the presence (Table 3) of glucose, and at all ages tested (Table 2) . On the contrary, phenylalanine at the same concentration had no effect on the metabolism ofketone bodies by rat brainslices. . Lineweaver-Burk plots ofthe effect ofphenylpyruvate on the activity of 2-oxoglutarate dehydrogenase complex from adult rat (a) and human (b) brains The reaction mixture contained, in a final volume of I ml: 11mM-potassium phosphate buffer, pH7.4; 1.1 mmdithiothreitol; 1.1 mM-EDTA; 3MM-MgCI2; 0. mMthiamin pyrophosphate; 0.2mM-CoA; 2mM-NAD+ and about 0.3mg of mitochondrial protein. 2-Oxo[I-14C1-glutarate (sp. radioactivity 50d.p.m./nmol) was varied as indicated. Other additions were: *, none; A, phenylpyruvate (5 mM for human brain and 1 mm for rat brain). The activity of 2-oxoglutarate dehydrogenase complex in mitochondria from adult rat brain and in crude particulate preparation from adult human brain (autopsy specimen) was assayed as described. A munit of activity is defined as 1 nmol of 2-oxo[1-"IC]glutarate decarboxylated to 14C02/min per mg of mitochondrial protein for rat brain and g wet wt. for human brain at 37°C.
Vol. 154 tion into cerebral lipids was markedly inhibited by this oxo acid (Table 3) . Again, phenylalanine had no effect on the metabolism of labelled glucose and acetate.
Previous studies (Foster & Katz, 1966; Jungas, 1968) have shown that the incorporation of 3H from 3H20 is proportional to the total rate of lipogenesis by rat adipose tissue. We have used this approach to measure the total rate of lipid synthesis from ketone bodies in the presence of either phenylalanine or phenylpyruvate. Phenylpyruvate, but not phenylalanine, inhibited the incorporation of 3H from 3H20 into lipids by brain slices metabolizing either acetoacetate or 3-hydroxybutyrate in the presence of glucose (Table 4 ). These findings suggest that the availability of the acetyl moieties for lipogenesis may be limiting in the presence of phenylpyruvate.
In preliminary experiments we observed that both phenylalanine and phenylpyruvate had no inhibitory effect on the activities of 3-hydroxybutyrate dehydrogenase, 3-oxo acid CoA-transferase and acetoacetylCoA thiolase (soluble plus mitochondrial) in adult rat brain (results not shown). Because phenylpyruvate interfered with the assay of activity of 3-hydroxybutyrate dehydrogenase by the colorimetric assay of Walker (1954) , a commercially available 3-hydroxybutyrate dehydrogenase preparation was assayed spectrophotometrically by the method of Smith et al. (1969) . With this approach, no effect of phenylpyruvate was noted on this enzyme.
As shown in Fig. 1 , Km values for 2-oxoglutarate of the 2-oxoglutarate dehydrogenase complex from human and rat brain preparations were 85 and 100pM respectively. These findings are similar to those reported by Patel (1974b) . Phenylpyruvate competitively inhibited the 2-oxoglutarate dehydrogenase complexes from adult human and rat brains, with an apparent K, of about 1.6mm. Phenylpyruvate also inhibited in a similar manner the activity of this enzyme from human foetal brain and 2-week-old rat brain (results not shown).
Discussion
During the postnatal period the developing mammalian brain rapidly metabolizes both glucose and ketone bodies (for a review see Krebs et al., 1971) . In fact, the rate of metabolism of ketone bodies at a given concentration is greater in the developing rat brain than in that of the adult . This is presumably due to the higher activities of ketone-body-utilizing enzymes in brains from developing rats . Edmond (1974) reported that ketone bodies are incorporated into cerebral lipids in vivo in 1-week-old rats. Our data extend (Tables 1 and 3 ) this observation and show that the biosynthesis of lipids in developing brains is greater with ketone bodies than with glucose.
Previous studies have shown that hyperphenylalaninaemia induced either in vitro (Weber et al., 1970) or in vivo (Miller et al., 1973) in rats diminished cerebral glycolysis by inhibiting hexokinase and pyruvate kinase. The transport of pyruvate across the inner mitochondrial membrane in rat brain mitochondria (Land & Clark, 1974; Halestrap etal., 1974) and its metabolism via pyruvate carboxylase in rat and human brain preparations (Patel, 1972; Patel et al., 1973) have been shown to be inhibited by phenylpyruvate (for a review see Patel & Arinze, 1975) . These and other findings (Shah et al., 1970) clearly show that the metabolism of glucose is impaired in brains of hyperphenylalaninaemic rat. A decrease in energy metabolism due to this impairment may be overcome in the developing brain by an increase in ketone-body oxidation. However, the findings reported in the present paper show that the metabolism of ketone bodies in vivo is also impaired in brains of hyperphenylalaninaemic rats (Table 1) (Agrawal et al., 1970; Swaiman et al., 1968) , and/or (ii) an inhibition of one or more enzyme activities, as discussed below. However, in acute hyperphenylalaninaemic rats (Table 1) and in experiments in vitro (Tables 2 and 3 ) the inhibition of cerebral lipid synthesis from labelled ketone bodies was mostly due to the inhibition of the activity of the enzyme(s) by phenylpyruvate.
Previous studies (Patel, 1972; Patel et al., 1973; Land & Clark, 1973) have shown that several enzymes involved in the biosynthesis of fatty acids from pyruvate in the brain are inhibited by phenylpyruvate. This includes the mitochondrial enzymes, namely pyruvate carboxylase and citrate synthase, and the cytosolic enzyme, fatty acid synthetase. These enzymes are also involved in the incorporation of the acetyl moiety formed in the mitochondria from ketone bodies into long-chain fatty acids synthesized de novo in the cytosol. The inhibition by phenylpyruvate of the 2-oxoglutarate dehydrogenase complex from rat and human brains as reported here (Fig. 1) is of some interest. In the mitochondria, acetoacetate is converted into acetoacetyl-CoA by the action of 2-oxo acid CoA-transferase in the presence ofsuccinyl-CoA. The latter is formed from 2-oxoglutarate by the 2-oxoglutarate dehydrogenase complex, and hence the inhibition of this enzyme by phenylpyruvate may decrease the metabolism of ketone bodies. Shah et al. (1968 Shah et al. ( , 1969 observed that the biosynthesis of sterols from [14C]mevalonate is inhibited by phenylpyruvate. Our present data (Tables 1-3 ) and those of Edmond (1974) demonstrated that ketone bodies are suitable precursors for the synthesis of sterols in the developing rat brain. Because phenylpyruvate markedly inhibits the incorporation of 14C-labelled ketone bodies into cerebral fatty acids and sterols, it is suggested that phenylpyruvate exerts its inhibitory effects at several points on these pathways. The common pathway for the flow of ketone-body carbon into these two pathways in the cytosol is up to the point at which the generation of the acetyl moiety occurs. An inhibition by phenylpyruvate up to this portion of the pathway should have an adverse effect on both pathways. This is consistent with the inhibitory effect of phenylpyruvate on the transport of 3-hydroxybutyrate across the inner mitochondrial membrane in rat brain mitochondria (Land & Clark, 1974) and on one or more mitochondrial enzymes as mentioned above ( Fig. 1 ; Patel, 1972; Land & Clark, 1973) . In addition to this, phenylpyruvate can also exert separate inhibitory effects on the remainder of the pathways distal to the branching point, for example, the inhibition of the fatty acid synthetase complex by phenylpyruvate (Land & Clark, 1973) . It is possible that phenylpyruvate decreases the formation of a common precursor(s) needed for the biosynthesis of both fatty acids and sterols. One such likely compound is NADPH. The pentose phosphate pathway and the cytosolic NADP+-malate dehydrogenase supply the reducing equivalents (NADPH) required for the reductive biosynthesis of these lipids (Flatt & Ball, 1966; Hanson & Ballard, 1968; Patel, 1974a) . Phenylpynivate inhibits brain 6-phosphogluconate dehydrogenase (EC 1.1.1.44) (Weber et al., 1970) and both the cytoplasmic and mitochondrial NADP+-malate dehydrogenases (EC 1.1.1.40) (M. S. Patel, unpublished work) . A decrease by phenylpyruvate in the generation and the incorpora-1976 tion of acetyl-CoA from ketone bodies and/or in NADPH in the cytosol is consistent with findings reported here. Our findings show that hyperphenylalaninaemia impairs the metabolism of ketone bodies for energy generation and lipid biosynthesis in developing rat brain. It is suggested that similar impairment in cerebral ketone-body metabolism in untreated phenylketonuric patients may, in part, contribute to mental retardation associated with phenylketonuria.
